Lehmann S - Search Results

1

Post-bronchodilator spirometry reference values in adults and implications for disease management.

Johannessen A, Lehmann S, Omenaas ER, Eide GE, Bakke PS, Gulsvik A. Johannessen A, et al. Among authors: lehmann s. Am J Respir Crit Care Med. 2006 Jun 15;173(12):1316-25. doi: 10.1164/rccm.200601-023OC. Epub 2006 Mar 23. Am J Respir Crit Care Med. 2006. PMID: 16556696

2

Factors determining performance of bronchodilator reversibility tests in middle-aged and elderly.

Lehmann S, Vollset SE, Nygaard HA, Gulsvik A. Lehmann S, et al. Respir Med. 2004 Nov;98(11):1071-9. doi: 10.1016/j.rmed.2004.03.019. Respir Med. 2004. PMID: 15526807 Free article.

3

Bronchodilator reversibility testing in an adult general population; the importance of smoking and anthropometrical variables on the response to a beta2-agonist.

Lehmann S, Bakke PS, Eide GE, Humerfelt S, Gulsvik A. Lehmann S, et al. Pulm Pharmacol Ther. 2006;19(4):272-80. doi: 10.1016/j.pupt.2005.07.006. Epub 2005 Sep 19. Pulm Pharmacol Ther. 2006. PMID: 16169762

4

Bronchodilator response to adrenergic beta2-agonists: relationship to symptoms in an adult community.

Lehmann S, Bakke PS, Eide GE, Gulsvik A. Lehmann S, et al. Respir Med. 2007 Jun;101(6):1183-90. doi: 10.1016/j.rmed.2006.11.007. Epub 2006 Dec 22. Respir Med. 2007. PMID: 17188486 Free article.

5

Clinical data discriminating between adults with positive and negative results on bronchodilator testing.

Lehmann S, Bakke PS, Eide GE, Gulsvik A. Lehmann S, et al. Int J Tuberc Lung Dis. 2008 Feb;12(2):205-13. Int J Tuberc Lung Dis. 2008. PMID: 18230255

6

Norwegian population surveys on respiratory health in adults: objectives, design, methods, quality controls and response rates.

Gulsvik A, Humerfelt S, Bakke PS, Omenaas ER, Lehmann S. Gulsvik A, et al. Among authors: lehmann s. Clin Respir J. 2008 Oct;2 Suppl 1:10-25. doi: 10.1111/j.1752-699X.2008.00080.x. Clin Respir J. 2008. PMID: 20298346

7

Prevalence and predictors of undiagnosed chronic obstructive pulmonary disease in a Norwegian adult general population.

Hvidsten SC, Storesund L, Wentzel-Larsen T, Gulsvik A, Lehmann S. Hvidsten SC, et al. Among authors: lehmann s. Clin Respir J. 2010 Jan;4(1):13-21. doi: 10.1111/j.1752-699X.2009.00137.x. Clin Respir J. 2010. PMID: 20298413

8

Rosuvastatin treatment in stable chronic obstructive pulmonary disease (RODEO): a randomized controlled trial.

Neukamm A, Høiseth AD, Einvik G, Lehmann S, Hagve TA, Søyseth V, Omland T. Neukamm A, et al. Among authors: lehmann s. J Intern Med. 2015 Jul;278(1):59-67. doi: 10.1111/joim.12337. Epub 2015 Jan 5. J Intern Med. 2015. PMID: 25495178 Free article. Clinical Trial.

9

Prevalence of excessive sleepiness is higher whereas insomnia is lower with greater severity of obstructive sleep apnea.

Bjorvatn B, Lehmann S, Gulati S, Aurlien H, Pallesen S, Saxvig IW. Bjorvatn B, et al. Among authors: lehmann s. Sleep Breath. 2015 Dec;19(4):1387-93. doi: 10.1007/s11325-015-1155-5. Epub 2015 Apr 9. Sleep Breath. 2015. PMID: 25855469

10

Associations between obstructive lung disease and symptoms of obstructive sleep apnoea in a general population.

Jonassen TM, Eagan TM, Bjorvatn B, Lehmann S. Jonassen TM, et al. Among authors: lehmann s. Clin Respir J. 2018 Jan;12(1):31-39. doi: 10.1111/crj.12472. Epub 2016 Mar 31. Clin Respir J. 2018. PMID: 26948980

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results